glp 1 for metabolic syndrome and Type II Diabetes: Part 3 The GLP-1 revolution: What UAB
Description
healthcare system [68]
Such studies are continuing for patients without cancer (NCT05786521, NCT06811324, and NCT06497595) (80) and are being initiated in the context of cancer (NCT06751589)
However, theres little to no data on other GLP1 medications like tirzepatide (Mounjaro) or liraglutide
Country of Origin: Made in USA
